<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-12-15" modified="2017-10-25" version="170">
<accession>P78329</accession>
<accession>A0A024R7K3</accession>
<accession>A8K425</accession>
<accession>B4DV75</accession>
<accession>Q16677</accession>
<accession>Q6NWT4</accession>
<accession>Q6NWT6</accession>
<accession>Q9NNZ0</accession>
<accession>Q9UIU8</accession>
<name>CP4F2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="21">Phylloquinone omega-hydroxylase CYP4F2</fullName>
<ecNumber evidence="15">1.14.13.194</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="19">20-hydroxyeicosatetraenoic acid synthase</fullName>
<shortName evidence="19">20-HETE synthase</shortName>
<ecNumber evidence="3">1.14.13.-</ecNumber>
</alternativeName>
<alternativeName>
<fullName evidence="19">Arachidonic acid omega-hydroxylase</fullName>
</alternativeName>
<alternativeName>
<fullName>CYPIVF2</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450 4F2</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450-LTB-omega</fullName>
</alternativeName>
<alternativeName>
<fullName>Leukotriene-B(4) 20-monooxygenase 1</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="21">Leukotriene-B(4) omega-hydroxylase 1</fullName>
<ecNumber evidence="16 17">1.14.13.30</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="22">CYP4F2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="FEBS Lett." volume="348" first="70" last="74">
<title>Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver.</title>
<authorList>
<person name="Kikuta Y."/>
<person name="Kusunose E."/>
<person name="Kondo T."/>
<person name="Yamamoto S."/>
<person name="Kinoshita H."/>
<person name="Kusunose M."/>
</authorList>
<dbReference type="PubMed" id="8026587"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)00587-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="DNA Cell Biol." volume="18" first="723" last="730">
<title>Expression and molecular cloning of human liver leukotriene B4 omega-hydroxylase (CYP4F2) gene.</title>
<authorList>
<person name="Kikuta Y."/>
<person name="Miyauchi Y."/>
<person name="Kusunose E."/>
<person name="Kusunose M."/>
</authorList>
<dbReference type="PubMed" id="10492403"/>
<dbReference type="DOI" id="10.1089/104454999315006"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="submission" date="2000-07" db="EMBL/GenBank/DDBJ databases">
<title>The human liver CYP4F2 cDNA sequence and expression in baculovirus-infected insect cells.</title>
<authorList>
<person name="Chen L."/>
<person name="Hardwick J.P."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT VAL-185</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Small intestine</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2002-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS TYR-7; GLY-12; VAL-185; MET-433 AND MET-519</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS GLY-12 AND MET-433</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Arch. Biochem. Biophys." volume="378" first="364" last="376">
<title>Promoter activity and regulation of the CYP4F2 leukotriene B4 omega hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells.</title>
<authorList>
<person name="Zhang X."/>
<person name="Chen L."/>
<person name="Hardwick J.P."/>
</authorList>
<dbReference type="PubMed" id="10860554"/>
<dbReference type="DOI" id="10.1006/abbi.2000.1836"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-175</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Arch. Biochem. Biophys." volume="359" first="89" last="98">
<title>Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4.</title>
<authorList>
<person name="Jin R."/>
<person name="Koop D.R."/>
<person name="Raucy J.L."/>
<person name="Lasker J.M."/>
</authorList>
<dbReference type="PubMed" id="9799565"/>
<dbReference type="DOI" id="10.1006/abbi.1998.0880"/>
</citation>
<scope>PROTEIN SEQUENCE OF 5-21</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>VARIANT GLY-12</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="4118" last="4126">
<title>Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11.</title>
<authorList>
<person name="Lasker J.M."/>
<person name="Chen W.B."/>
<person name="Wolf I."/>
<person name="Bloswick B.P."/>
<person name="Wilson P.D."/>
<person name="Powell P.K."/>
</authorList>
<dbReference type="PubMed" id="10660572"/>
<dbReference type="DOI" id="10.1074/jbc.275.6.4118"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Physiol. Genomics" volume="30" first="74" last="81">
<title>Functional polymorphism in human CYP4F2 decreases 20-HETE production.</title>
<authorList>
<person name="Stec D.E."/>
<person name="Roman R.J."/>
<person name="Flasch A."/>
<person name="Rieder M.J."/>
</authorList>
<dbReference type="PubMed" id="17341693"/>
<dbReference type="DOI" id="10.1152/physiolgenomics.00003.2007"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Hypertension" volume="52" first="373" last="380">
<title>The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure.</title>
<authorList>
<person name="Fava C."/>
<person name="Montagnana M."/>
<person name="Almgren P."/>
<person name="Rosberg L."/>
<person name="Lippi G."/>
<person name="Hedblad B."/>
<person name="Engstrom G."/>
<person name="Berglund G."/>
<person name="Minuz P."/>
<person name="Melander O."/>
</authorList>
<dbReference type="PubMed" id="18574070"/>
<dbReference type="DOI" id="10.1161/HYPERTENSIONAHA.108.114199"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Blood" volume="111" first="4106" last="4112">
<title>CYP4F2 genetic variant alters required warfarin dose.</title>
<authorList>
<person name="Caldwell M.D."/>
<person name="Awad T."/>
<person name="Johnson J.A."/>
<person name="Gage B.F."/>
<person name="Falkowski M."/>
<person name="Gardina P."/>
<person name="Hubbard J."/>
<person name="Turpaz Y."/>
<person name="Langaee T.Y."/>
<person name="Eby C."/>
<person name="King C.R."/>
<person name="Brower A."/>
<person name="Schmelzer J.R."/>
<person name="Glurich I."/>
<person name="Vidaillet H.J."/>
<person name="Yale S.H."/>
<person name="Qi Zhang K."/>
<person name="Berg R.L."/>
<person name="Burmester J.K."/>
</authorList>
<dbReference type="PubMed" id="18250228"/>
<dbReference type="DOI" id="10.1182/blood-2007-11-122010"/>
</citation>
<scope>INVOLVEMENT IN CMRES</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Blood" volume="113" first="4977" last="4979">
<title>Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy.</title>
<authorList>
<person name="Perez-Andreu V."/>
<person name="Roldan V."/>
<person name="Anton A.I."/>
<person name="Garcia-Barbera N."/>
<person name="Corral J."/>
<person name="Vicente V."/>
<person name="Gonzalez-Conejero R."/>
</authorList>
<dbReference type="PubMed" id="19270263"/>
<dbReference type="DOI" id="10.1182/blood-2008-09-176222"/>
</citation>
<scope>INVOLVEMENT IN CMRES</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Mol. Pharmacol." volume="75" first="1337" last="1346">
<title>CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.</title>
<authorList>
<person name="McDonald M.G."/>
<person name="Rieder M.J."/>
<person name="Nakano M."/>
<person name="Hsia C.K."/>
<person name="Rettie A.E."/>
</authorList>
<dbReference type="PubMed" id="19297519"/>
<dbReference type="DOI" id="10.1124/mol.109.054833"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INVOLVEMENT IN CMRES</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Pharmacogenomics" volume="10" first="261" last="266">
<title>CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.</title>
<authorList>
<person name="Borgiani P."/>
<person name="Ciccacci C."/>
<person name="Forte V."/>
<person name="Sirianni E."/>
<person name="Novelli L."/>
<person name="Bramanti P."/>
<person name="Novelli G."/>
</authorList>
<dbReference type="PubMed" id="19207028"/>
<dbReference type="DOI" id="10.2217/14622416.10.2.261"/>
</citation>
<scope>INVOLVEMENT IN CMRES</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="J. Hum. Genet." volume="55" first="582" last="589">
<title>Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements.</title>
<authorList>
<person name="Ross K.A."/>
<person name="Bigham A.W."/>
<person name="Edwards M."/>
<person name="Gozdzik A."/>
<person name="Suarez-Kurtz G."/>
<person name="Parra E.J."/>
</authorList>
<dbReference type="PubMed" id="20555338"/>
<dbReference type="DOI" id="10.1038/jhg.2010.73"/>
</citation>
<scope>INVOLVEMENT IN CMRES</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="J. Nutr." volume="140" first="1901" last="1906">
<title>Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.</title>
<authorList>
<person name="Bardowell S.A."/>
<person name="Stec D.E."/>
<person name="Parker R.S."/>
</authorList>
<dbReference type="PubMed" id="20861217"/>
<dbReference type="DOI" id="10.3945/jn.110.128579"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2012" name="Clin. Pharmacol. Ther." volume="92" first="746" last="756">
<title>Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.</title>
<authorList>
<person name="Danese E."/>
<person name="Montagnana M."/>
<person name="Johnson J.A."/>
<person name="Rettie A.E."/>
<person name="Zambon C.F."/>
<person name="Lubitz S.A."/>
<person name="Suarez-Kurtz G."/>
<person name="Cavallari L.H."/>
<person name="Zhao L."/>
<person name="Huang M."/>
<person name="Nakamura Y."/>
<person name="Mushiroda T."/>
<person name="Kringen M.K."/>
<person name="Borgiani P."/>
<person name="Ciccacci C."/>
<person name="Au N.T."/>
<person name="Langaee T."/>
<person name="Siguret V."/>
<person name="Loriot M.A."/>
<person name="Sagreiya H."/>
<person name="Altman R.B."/>
<person name="Shahin M.H."/>
<person name="Scott S.A."/>
<person name="Khalifa S.I."/>
<person name="Chowbay B."/>
<person name="Suriapranata I.M."/>
<person name="Teichert M."/>
<person name="Stricker B.H."/>
<person name="Taljaard M."/>
<person name="Botton M.R."/>
<person name="Zhang J.E."/>
<person name="Pirmohamed M."/>
<person name="Zhang X."/>
<person name="Carlquist J.F."/>
<person name="Horne B.D."/>
<person name="Lee M.T."/>
<person name="Pengo V."/>
<person name="Guidi G.C."/>
<person name="Minuz P."/>
<person name="Fava C."/>
</authorList>
<dbReference type="PubMed" id="23132553"/>
<dbReference type="DOI" id="10.1038/clpt.2012.184"/>
</citation>
<scope>INVOLVEMENT IN CMRES</scope>
<scope>CHARACTERIZATION OF VARIANT MET-433</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Biochemistry" volume="52" first="8276" last="8285">
<title>Cytochrome P450-dependent catabolism of vitamin K: omega-hydroxylation catalyzed by human CYP4F2 and CYP4F11.</title>
<authorList>
<person name="Edson K.Z."/>
<person name="Prasad B."/>
<person name="Unadkat J.D."/>
<person name="Suhara Y."/>
<person name="Okano T."/>
<person name="Guengerich F.P."/>
<person name="Rettie A.E."/>
</authorList>
<dbReference type="PubMed" id="24138531"/>
<dbReference type="DOI" id="10.1021/bi401208m"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INVOLVEMENT IN CMRES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="3 6 8 11 15 16 17">Omega-hydroxylase that oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids and xenobiotics. Plays a key role in vitamin K catabolism by mediating omega-hydroxylation of vitamin K1 (phylloquinone), and menaquinone-4 (MK-4), a form of vitamin K2. Hydroxylation of phylloquinone and MK-4 probably regulates blood coagulation (PubMed:19297519, PubMed:24138531). Also shows arachidonic acid omega-hydroxylase activity in kidney, by mediating conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), possibly influencing blood pressure control (PubMed:10660572, PubMed:17341693, PubMed:18574070). Also acts as a leukotriene-B(4) omega-hydroxylase by mediating conversion of leukotriene-B(4) (LTB4) to its omega-hydroxylated metabolite 20-hydroxyleukotriene-B(4) (20-OH LTB4) (PubMed:8026587, PubMed:9799565).</text>
</comment>
<comment type="catalytic activity">
<text evidence="16 17">(6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate + NADPH + O(2) = (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoate + NADP(+) + H(2)O.</text>
</comment>
<comment type="catalytic activity">
<text evidence="15">Phylloquinone + NADPH + O(2) = omega-hydroxyphylloquinone + NADP(+) + H(2)O.</text>
</comment>
<comment type="catalytic activity">
<text evidence="3">(5Z,8Z,11Z,14Z)-icosatetraenoate + NADPH + O(2) = (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoate + NADP(+) + H(2)O.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="1">
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="17">74.8 uM for leukotriene-B(4)</KM>
<KM evidence="15">1.7 uM for menaquinone-4 (MK-4)</KM>
<Vmax evidence="17">2.42 nmol/min/mg enzyme</Vmax>
<text evidence="15">kcat is 0.067 min(-1) with menaquinone-4 (MK-4) as substrate.</text>
</kinetics>
</comment>
<comment type="pathway" evidence="15">
<text>Cofactor degradation; phylloquinone degradation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1752413"/>
<interactant intactId="EBI-625022">
<id>O43889-2</id>
<label>CREB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1752413"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 15 16">Microsome membrane</location>
<topology evidence="21">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Endoplasmic reticulum membrane</location>
<topology evidence="21">Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P78329-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P78329-2</id>
<name>2</name>
<sequence type="described" ref="VSP_055578 VSP_055579 VSP_055580"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="2 3">Liver. Also present in kidney: specifically expressed in the S2 and S3 segments of proximal tubules in cortex and outer medulla (PubMed:10660572).</text>
</comment>
<comment type="disease" evidence="7 9 10 11 12 14 15">
<disease id="DI-01438">
<name>Coumarin resistance</name>
<acronym>CMRES</acronym>
<description>A condition characterized by partial or complete resistance to warfarin or other 4-hydroxycoumarin derivatives. These drugs are used as anti-coagulants for the prevention of thromboembolic diseases in subjects with deep vein thrombosis, atrial fibrillation, or mechanical heart valve replacement.</description>
<dbReference type="MIM" id="122700"/>
</disease>
<text evidence="15">Disease susceptibility may be associated with variations affecting the gene represented in this entry. The variant Met-433 is associated with coumarin (the brand name of warfarin) resistance by increasing coumarin maintenance dose in patients on this anti-coagulant therapy. This is probably due to decreased activity of the phylloquinone omega-hydroxylase activity, leading to an increase in hepatic vitamin K levels that warfarin must antagonize (PubMed:24138531).</text>
</comment>
<comment type="similarity">
<text evidence="21">Belongs to the cytochrome P450 family.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/cyp4f2/"/>
</comment>
<dbReference type="EC" id="1.14.13.194" evidence="15"/>
<dbReference type="EC" id="1.14.13.-" evidence="3"/>
<dbReference type="EC" id="1.14.13.30" evidence="16 17"/>
<dbReference type="EMBL" id="D26480">
<property type="protein sequence ID" value="BAA05490.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB015306">
<property type="protein sequence ID" value="BAA75823.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U02388">
<property type="protein sequence ID" value="AAC50052.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290790">
<property type="protein sequence ID" value="BAF83479.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300961">
<property type="protein sequence ID" value="BAG62587.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF467894">
<property type="protein sequence ID" value="AAL67578.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005336">
<property type="protein sequence ID" value="AAC27730.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004791">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471106">
<property type="protein sequence ID" value="EAW84509.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471106">
<property type="protein sequence ID" value="EAW84510.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC067437">
<property type="protein sequence ID" value="AAH67437.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC067439">
<property type="protein sequence ID" value="AAH67439.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC067440">
<property type="protein sequence ID" value="AAH67440.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF221943">
<property type="protein sequence ID" value="AAF86378.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12336.1">
<molecule id="P78329-1"/>
</dbReference>
<dbReference type="PIR" id="S45702">
<property type="entry name" value="S45702"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001073.3">
<molecule id="P78329-1"/>
<property type="nucleotide sequence ID" value="NM_001082.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.558423"/>
<dbReference type="ProteinModelPortal" id="P78329"/>
<dbReference type="SMR" id="P78329"/>
<dbReference type="BioGrid" id="114099">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="P78329">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000221700"/>
<dbReference type="BindingDB" id="P78329"/>
<dbReference type="ChEMBL" id="CHEMBL3379"/>
<dbReference type="DrugBank" id="DB08868">
<property type="generic name" value="Fingolimod"/>
</dbReference>
<dbReference type="DrugBank" id="DB09148">
<property type="generic name" value="Florbetaben (18F)"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1344"/>
<dbReference type="SwissLipids" id="SLP:000000421"/>
<dbReference type="iPTMnet" id="P78329"/>
<dbReference type="PhosphoSitePlus" id="P78329"/>
<dbReference type="BioMuta" id="CYP4F2"/>
<dbReference type="DMDM" id="6166044"/>
<dbReference type="MaxQB" id="P78329"/>
<dbReference type="PaxDb" id="P78329"/>
<dbReference type="PeptideAtlas" id="P78329"/>
<dbReference type="PRIDE" id="P78329"/>
<dbReference type="Ensembl" id="ENST00000221700">
<molecule id="P78329-1"/>
<property type="protein sequence ID" value="ENSP00000221700"/>
<property type="gene ID" value="ENSG00000186115"/>
</dbReference>
<dbReference type="GeneID" id="8529"/>
<dbReference type="KEGG" id="hsa:8529"/>
<dbReference type="UCSC" id="uc002nbs.2">
<molecule id="P78329-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8529"/>
<dbReference type="DisGeNET" id="8529"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000186115.12"/>
<dbReference type="GeneCards" id="CYP4F2"/>
<dbReference type="HGNC" id="HGNC:2645">
<property type="gene designation" value="CYP4F2"/>
</dbReference>
<dbReference type="HPA" id="HPA014048"/>
<dbReference type="HPA" id="HPA058960"/>
<dbReference type="MalaCards" id="CYP4F2"/>
<dbReference type="MIM" id="122700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604426">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P78329"/>
<dbReference type="OpenTargets" id="ENSG00000186115"/>
<dbReference type="Orphanet" id="413674">
<property type="disease" value="Vitamin K antagonists toxicity or dose selection"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27121"/>
<dbReference type="eggNOG" id="KOG0157">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2124">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140829"/>
<dbReference type="HOVERGEN" id="HBG000182"/>
<dbReference type="InParanoid" id="P78329"/>
<dbReference type="KO" id="K17726"/>
<dbReference type="OMA" id="AYNHEPN"/>
<dbReference type="PhylomeDB" id="P78329"/>
<dbReference type="TreeFam" id="TF105088"/>
<dbReference type="BioCyc" id="MetaCyc:HS02675-MONOMER"/>
<dbReference type="BRENDA" id="1.14.13.30">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211935">
<property type="pathway name" value="Fatty acids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211958">
<property type="pathway name" value="Miscellaneous substrates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211979">
<property type="pathway name" value="Eicosanoids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2142691">
<property type="pathway name" value="Synthesis of Leukotrienes (LT) and Eoxins (EX)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2142816">
<property type="pathway name" value="Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)"/>
</dbReference>
<dbReference type="UniPathway" id="UPA01054"/>
<dbReference type="GeneWiki" id="CYP4F2"/>
<dbReference type="GenomeRNAi" id="8529"/>
<dbReference type="PRO" id="PR:P78329"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000186115"/>
<dbReference type="CleanEx" id="HS_CYP4F2"/>
<dbReference type="ExpressionAtlas" id="P78329">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P78329">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031090">
<property type="term" value="C:organelle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0097259">
<property type="term" value="F:20-aldehyde-leukotriene B4 20-monooxygenase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097258">
<property type="term" value="F:20-hydroxy-leukotriene B4 omega oxidase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018685">
<property type="term" value="F:alkane 1-monooxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052871">
<property type="term" value="F:alpha-tocopherol omega-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008392">
<property type="term" value="F:arachidonic acid epoxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0052869">
<property type="term" value="F:arachidonic acid omega-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050051">
<property type="term" value="F:leukotriene-B4 20-monooxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004497">
<property type="term" value="F:monooxygenase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016709">
<property type="term" value="F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0052872">
<property type="term" value="F:tocotrienol omega-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019369">
<property type="term" value="P:arachidonic acid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017144">
<property type="term" value="P:drug metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019373">
<property type="term" value="P:epoxygenase P450 pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006690">
<property type="term" value="P:icosanoid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036101">
<property type="term" value="P:leukotriene B4 catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006691">
<property type="term" value="P:leukotriene metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001676">
<property type="term" value="P:long-chain fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042361">
<property type="term" value="P:menaquinone catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032304">
<property type="term" value="P:negative regulation of icosanoid secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097267">
<property type="term" value="P:omega-hydroxylase P450 pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0055114">
<property type="term" value="P:oxidation-reduction process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042376">
<property type="term" value="P:phylloquinone catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032305">
<property type="term" value="P:positive regulation of icosanoid secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003095">
<property type="term" value="P:pressure natriuresis"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008217">
<property type="term" value="P:regulation of blood pressure"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003091">
<property type="term" value="P:renal water homeostasis"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055078">
<property type="term" value="P:sodium ion homeostasis"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000038">
<property type="term" value="P:very long-chain fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042360">
<property type="term" value="P:vitamin E metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042377">
<property type="term" value="P:vitamin K catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001128">
<property type="entry name" value="Cyt_P450"/>
</dbReference>
<dbReference type="InterPro" id="IPR017972">
<property type="entry name" value="Cyt_P450_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002401">
<property type="entry name" value="Cyt_P450_E_grp-I"/>
</dbReference>
<dbReference type="InterPro" id="IPR036396">
<property type="entry name" value="Cyt_P450_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00067">
<property type="entry name" value="p450"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00463">
<property type="entry name" value="EP450I"/>
</dbReference>
<dbReference type="PRINTS" id="PR00385">
<property type="entry name" value="P450"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48264">
<property type="entry name" value="SSF48264"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00086">
<property type="entry name" value="CYTOCHROME_P450"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0503">Monooxygenase</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="propeptide" id="PRO_0000430581" evidence="17">
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="chain" description="Phylloquinone omega-hydroxylase CYP4F2" id="PRO_0000051850">
<location>
<begin position="5"/>
<end position="520"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme axial ligand)" evidence="1">
<location>
<position position="468"/>
</location>
</feature>
<feature type="binding site" description="Heme (covalent; via 1 link)" evidence="1">
<location>
<position position="328"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_055578" evidence="20">
<location>
<begin position="1"/>
<end position="149"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_055579" evidence="20">
<original>DEDGKKLSDEDIRAEADTFMFEGHDTTASGLSW</original>
<variation>AMTPRPVVSPGSCTTLQSTQNTRSAAGRRCKNF</variation>
<location>
<begin position="307"/>
<end position="339"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_055580" evidence="20">
<location>
<begin position="340"/>
<end position="520"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3093104." id="VAR_013116" evidence="18">
<original>S</original>
<variation>Y</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3093105." id="VAR_013117" evidence="5 17 18">
<original>W</original>
<variation>G</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3093153." id="VAR_013118" evidence="4 18">
<original>G</original>
<variation>V</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1805040." id="VAR_020125">
<original>A</original>
<variation>D</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism probably associated with CMRES; increases warfarin maintenance dose in patients on warfarin anti-coagulant therapy, possibly due to increased hepatic vitamin K levels that warfarin must antagonize. Decreased phylloquinone omega-hydroxylase activity. Decreased production of 20-hydroxyeicosatetraenoic acid (20-HETE); dbSNP:rs2108622." id="VAR_013119" evidence="5 6 7 8 9 10 11 12 14 18">
<original>V</original>
<variation>M</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3093200." id="VAR_013120" evidence="18">
<original>L</original>
<variation>M</variation>
<location>
<position position="519"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC50052 and 9; AAF86378." ref="3 9" evidence="21">
<original>WP</original>
<variation>CR</variation>
<location>
<begin position="12"/>
<end position="13"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAH67437." ref="8" evidence="21">
<original>V</original>
<variation>A</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAH67440." ref="8" evidence="21">
<original>E</original>
<variation>D</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC50052." ref="3" evidence="21">
<original>G</original>
<variation>V</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC50052." ref="3" evidence="21">
<original>L</original>
<variation>V</variation>
<location>
<position position="391"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P24464"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10492403"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10660572"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17341693"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18250228"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18574070"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19207028"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19270263"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19297519"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20555338"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20861217"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23132553"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24138531"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8026587"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9799565"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10660572"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000305"/>
<evidence key="22" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:2645"/>
</source>
</evidence>
<sequence length="520" mass="59853" checksum="1791F9E6EECB59B5" modified="1997-05-01" version="1" precursor="true">
MSQLSLSWLGLWPVAASPWLLLLLVGASWLLAHVLAWTYAFYDNCRRLRCFPQPPRRNWF
WGHQGMVNPTEEGMRVLTQLVATYPQGFKVWMGPISPLLSLCHPDIIRSVINASAAIAPK
DKFFYSFLEPWLGDGLLLSAGDKWSRHRRMLTPAFHFNILKPYMKIFNESVNIMHAKWQL
LASEGSACLDMFEHISLMTLDSLQKCVFSFDSHCQEKPSEYIAAILELSALVSKRHHEIL
LHIDFLYYLTPDGQRFRRACRLVHDFTDAVIQERRRTLPSQGVDDFLQAKAKSKTLDFID
VLLLSKDEDGKKLSDEDIRAEADTFMFEGHDTTASGLSWVLYHLAKHPEYQERCRQEVQE
LLKDREPKEIEWDDLAHLPFLTMCMKESLRLHPPVPVISRHVTQDIVLPDGRVIPKGIIC
LISVFGTHHNPAVWPDPEVYDPFRFDPENIKERSPLAFIPFSAGPRNCIGQTFAMAEMKV
VLALTLLRFRVLPDHTEPRRKPELVLRAEGGLWLRVEPLS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>